An Overview of Laboratory Testing for Antiphospholipid Antibodies

Emmanuel J Favaloro, Leonardo Pasalic

Research output: Contribution to journalArticlepeer-review


Antiphospholipid antibodies (aPL) represent a group of autoantibodies directed against phospholipids. These antibodies may arise in a number of autoimmune conditions, of which the antiphospholipid (antibody) syndrome (APS) is best recognized. aPL can be detected by various laboratory assays, essentially comprising both solid-phase (immunological) assays and "liquid-phase" clotting assays identifying so-called lupus anticoagulants (LA). aPL are associated with various adverse pathologies, including thrombosis and placental/fetal morbidity and mortality. The type of aPL present, as well as the pattern of reactivity, is variously associated with the severity of the pathology. Thus, laboratory testing for aPL is indicated to help assess the future risk of such events, as well as representing certain "classification" criteria for APS, also used as surrogates for diagnostic criteria. The current chapter overviews the laboratory tests available to measure aPL and their potential clinical utility.

Original languageEnglish
Pages (from-to)253-262
Number of pages10
JournalMethods in Molecular Biology
Publication statusPublished - 2023


Dive into the research topics of 'An Overview of Laboratory Testing for Antiphospholipid Antibodies'. Together they form a unique fingerprint.

Cite this